Sintetica SA
Quick facts
| Founded | 1921 |
|---|
Marketed products
- Chloroprocaine 1% Injectable Solution · Anesthesia
Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses. - Hyperbaric Bupivacaine HCl 0.5%
Phase 3 pipeline
- Chloroprocaine 3% · Anesthesia
Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses. - Chloroprocaine 3% eye gel · Ophthalmology
Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses in the eye. - Chloroprocaine HCl 2% · Anesthesia
Chloroprocaine HCl is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.
Phase 2 pipeline
- Chloroprocaine 2% Injectable Solution · Oncology
Local anesthetic by blocking sodium channels - Chloroprocaine HCl 1% · Anesthesiology
Chloroprocaine HCl 1% is a local anesthetic that works by blocking nerve impulses in the body. - Ocular gel
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Sintetica SA
What are Sintetica SA's marketed drugs?
Top marketed products include Chloroprocaine 1% Injectable Solution, Hyperbaric Bupivacaine HCl 0.5%.
What is Sintetica SA's pipeline?
Sintetica SA has 3 drugs in Phase 3, 3 in Phase 2, 1 in Phase 1. Late-stage candidates include Chloroprocaine 3%, Chloroprocaine 3% eye gel, Chloroprocaine HCl 2%.
When was Sintetica SA founded?
Sintetica SA was founded in 1921.
Related
- Chloroprocaine 1% Injectable Solution · Anesthesia
- Hyperbaric Bupivacaine HCl 0.5%
- Sector hub: All tracked pharma companies